MedX Health Corp Announces Operating Results For The Nine Months ended September 30, 2007

    MISSISSAUGA, ON, Nov. 29 /CNW/ - MedX Health Corp., a leader in the
development, manufacture and distribution of innovative phototherapy devices,
announces its results for the three and six months ended September 30, 2007.
    Revenue for the three months ended September 30, 2007 (Q3 2007) were
$308,754 compared to $508,115 for the three months ended September 30, 2006 a
significant decrease versus the same period last year.
    MedX incurred a net loss of $307,797 in Q3 2007 compared to a net loss of
$555,754 for the same period in the prior year.

                                   Q3           Q3        9 mos.       9 mos.
    Canadian $                   2007         2006         2007         2006
    Revenue                   308,754      508,115      966,351    2,027,370
    Gross Margin %                 70%          75%          73%          76%
    Income (Loss) from
     continued operations    (302,034)    (554,172)  (1,342,565)    (857,829)
    Income (Loss) from
     operations                (5,763)      (1,582)      (6,552)      (4,133)
    Net Income (Loss)
     for period              (307,797)    (555,754)  (1,349,117)    (861,962)
    Weighted Average no.
     of shares
     and diluted           15,043,937   15,043,937   15,043,937   14,498,559
    Loss per Common
     Share-basic and
     diluted                   ($0.02)      ($0.04)      ($0.09)      ($0.06)

    "The decline in sales is primarily a result of changing conditions in the
rehabilitation market. We have started an exciting new sales program whereby a
number of sales agents have joined our Rehab marketing effort, and our dental
program is beginning to show positive results." said Phil Passy, President &
CEO of MedX Health.

    Significant achievements during the quarter were as follows:

    -   Sales this quarter in the Canadian market increased by 33% over the
        same period last year,
    -   Continued development of new light therapy products and intellectual
        property associated thereto,
    -   Introduction of new dental phototherapy devices in Canada.

    About the Company - MedX, the phototherapy experts, are leaders in the
development, manufacture and distribution of innovative phototherapy medical
devices. MedX products offer effective treatment through a powerful and proven
modality - giving patients a rapid, drug free and non-invasive healing
solution. MedX products are used by practitioners in clinics, academic
facilities, and hospitals as well as by professional athletes and sports teams
to improve quality of life through accelerating healing and reducing pain.
MedX brand products are US FDA and Health Canada cleared and are produced in
an ISO 9001 and 13485 certified manufacturing and testing facility. For a
complete profile of MedX Health Corp. and its products visit

    %SEDAR: 00017466E

For further information:

For further information: Phil Passy, President and CEO, MedX Health
Corp., Telephone: (905) 826-0766, Email:

Organization Profile

MedX Health Corp.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890